SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012162
Filing Date
2016-04-13
Accepted
2016-04-13 16:15:27
Documents
4
Period of Report
2016-05-18
Effectiveness Date
2016-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228213zdef14a.htm DEF 14A 355072
2 G888483.JPG g888483.jpg GRAPHIC 14167
3 G24283BII001.GIF g24283bii001.gif GRAPHIC 66551
4 G24283BII002.GIF g24283bii002.gif GRAPHIC 123608
  Complete submission text file 0001047469-16-012162.txt   637033
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36020 | Film No.: 161569446
SIC: 2834 Pharmaceutical Preparations